Spartan Wealth Advisory Services LLC’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Sell
4,000
-350
-8% -$23.3K 0.02% 275
2026
Q1
$273K Buy
+4,350
New +$303K 0.02% 265

Other funds holding DXCM

Spartan Wealth Advisory Services LLC's DXCM Position: Q2 2026 in Review

Spartan Wealth Advisory Services LLC reduced its DexCom (DXCM) stake by 8% in Q2 2026, selling an estimated $23.3K and leaving 4,000 shares worth $269K. The position accounts for 0.02% of the portfolio, ranked #275.

Spartan Wealth Advisory Services LLC first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. The position peaked at $273K in Q1 2026. 919 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Spartan Wealth Advisory Services LLC held 4,000 shares of DexCom worth $269K as of Q2 2026.
  • Spartan Wealth Advisory Services LLC sold 350 DexCom shares in Q2 2026, an estimated $23.3K.
  • DexCom made up 0.02% of Spartan Wealth Advisory Services LLC's portfolio in Q2 2026, its #275 holding.
  • Spartan Wealth Advisory Services LLC first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
  • Spartan Wealth Advisory Services LLC's DexCom position peaked at $273K in Q1 2026.
  • 919 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Spartan Wealth Advisory Services LLC's 13F filing for Q2 2026, filed 5 Aug 2026.